Skip to main content
SpringerLink
Log in

Residual Thyroid Tissue on Postoperative Diagnostic 131 I Radioactive Whole-Body Scan After Surgery in Differentiated Thyroid Cancer: A Tertiary Referral Centre Experience

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Residual thyroid tissue after total thyroidectomy in differentiated thyroid cancers is considered an independent risk factor for recurrence. Guidelines recommend following up patients after surgery with thyroglobulin (Tg), neck ultrasonography, and occasionally whole-body radioactive scan. However, the results of serum thyroglobulin and whole-body radioiodine scan are often discordant. The present study was undertaken to determine the levels of serum-stimulated thyroglobulin to complement the findings of residual thyroid tissue in the radioactive whole-body scan. One hundred twenty-six patients had undergone a radioiodine (131 I) whole-body scan (WBS) during the study duration, and 121 were available for analysis. The thyroglobulin level (measured by the CLIA method) was recorded at the time of these scans. The data was analysed to determine the level of stimulated thyroglobulin correlating with residual thyroid tissue, locoregional, and distant metastasis as assessed by WBS. The presence of residual thyroid tissue was noted in an overwhelmingly high 94% of cases. Twenty-four of the 28 patients with stimulated Tg < 2 ng/dl had residual thyroid tissue on a WBS. The discordancy rate (positive moderate — large WBS and negative serum thyroglobulin) of 64.28% was seen. Using ROC the serum thyroglobulin cut-offs levels for the loco-regional disease were found to be 27.705 ng/dl and 94.770 ng/dl for distant metastasis. The results highlight the fact that serum Tg levels cannot be used as an accurate predictor of the extent of the remnant thyroid tissue. Irrespective of the quality of surgery, which was analysed based on the centre and surgical specialty, over 90% of cases had residual thyroid tissue on WBS. The use of only stimulated Tg levels for follow-up may be inaccurate. Serum Tg is a useful test along with radioactive whole-body scans to distinguish local disease, loco-regional disease, and distant metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bal CS, Padhy AK (2015) Radioiodine remnant ablation: a critical review. World J Nucl Med 14(3):144–155. https://doi.org/10.4103/1450-1147.163240

    Article  PubMed  PubMed Central  Google Scholar 

  2. Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020

    Article  PubMed  PubMed Central  Google Scholar 

  3. Indrasena BS (2017) Use of thyroglobulin as a tumour marker. World J Biol Chem 8(1):81–85. https://doi.org/10.4331/wjbc.v8.i1.81

    Article  PubMed  PubMed Central  Google Scholar 

  4. Silva F, Martin RJ, Figueroa J, Rincón F, Román D (2016) Variability of serum thyroglobulin levels in post- thyroidectomy patients with well-differentiated thyroid cancer: the ATA guidelines. P R Health Sci J 35(3):142–146

    PubMed  PubMed Central  Google Scholar 

  5. Vishal Rao US, Koya S, Gandla S et al (2018) Small-sized thyroid cancers-a single institutional experience in India. Indian J Surg Oncol 9(1):35–38. https://doi.org/10.1007/s13193-017-0673-y

    Article  CAS  PubMed  Google Scholar 

  6. Mathew IE, Mathew A (2017) Rising thyroid cancer incidence in Southern India: an epidemic of overdiagnosis? J Endocrine Soc 1(5):480–487

    Article  Google Scholar 

  7. Fratkin MJ, Newsome HH, Sharpe AR, Tatum JL (1983) Cervical distribution of iodine 131 following total thyroidectomy for thyroid cancer. Arch Surg 118(7):864–867

    Article  CAS  PubMed  Google Scholar 

  8. Salvatori MA, Raffaelli MA, Castaldi PA, Treglia GI, Rufini V, Perotti GE, Lombardi CP, Rubello D, Ardito GU, Bellantone R (2007) Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. Eur J Surgical Oncol 33(5):648–654

    Article  CAS  Google Scholar 

  9. Zucchelli G, Iervasi A, Ferdeghini M, Iervasi G (2009) Serum thyroglobulin measurement in the follow-up of patients treated for differentiated thyroid cancer. Q J Nucl Med Mol Imaging 53(5):482

    CAS  PubMed  Google Scholar 

  10. Silva F, Martin RJ, Figueroa J, Rincón F, Román D (2016) Variability of serum thyroglobulin levels in post thyroidectomy patients with well differentiated thyroid cancer and the ATA guidelines. P R Health Sci J 35(3):142–146

    PubMed  PubMed Central  Google Scholar 

  11. Phan HT, Jager PL, van der Wal JE, Sluiter WJ, Plukker JT, Dierckx RA, Wolffenbuttel BH, Links TP (2008) The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation. Eur J Endocrinol 158(1):77–83

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck Oncology, HCG Cancer Centre, Sampangi Ram Nagar, No 8, HCG Towers, P. Kalinga Rao Road, Bangalore, Karnataka, 560020, India

    Rachana Prasad, Vishal Rao, Anand Subash, Kinjal Shankar Majumdar, Piyush Sinha & Ravi C. Nayar

  2. Department of Otolaryngology Head and Neck Surgerym, RIMS, Ranchi, India

    Rachana Prasad

  3. Department of Surgical Oncology, AIIMS, Rishikesh, India

    Kinjal Shankar Majumdar

  4. Department of Head and Neck Oncology, Medanta Hospital, Lucknow, India

    Piyush Sinha

  5. Department of Nuclear Medicine and Imaging, HCG Cancer Centre, Bangalore, India

    Kumar Kallur

Authors
  1. Rachana Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vishal Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anand Subash
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kinjal Shankar Majumdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Piyush Sinha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kumar Kallur
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ravi C. Nayar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vishal Rao.

Ethics declarations

Ethics approval

IRB ethical clearance has been obtained for the study (ECR/386/Inst/KA/2013/RR-19).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prasad, R., Rao, V., Subash, A. et al. Residual Thyroid Tissue on Postoperative Diagnostic 131 I Radioactive Whole-Body Scan After Surgery in Differentiated Thyroid Cancer: A Tertiary Referral Centre Experience. Indian J Surg Oncol 13, 109–114 (2022). https://doi.org/10.1007/s13193-021-01357-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-021-01357-x

Keywords

Search

Navigation